{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Fayosim 91 Day]

RxCUI
1874537
RxNorm name
{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Fayosim 91 Day]
Display name
FAYOSIM 91 DAY (Pack)
Full name
{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Fayosim 91 Day]
Term type
BPCK
Status
Active
Strength
mixed
Dose form
Pack
Route
Pack
Updated
2026-11-16 14:58:43

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042017
Active start
042017
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
ethinyl estradiol0.02 MG / 1 EACHethinyl estradiolethinyl estradiol
ethinyl estradiol0.025 MG / 1 EACHethinyl estradiolethinyl estradiol
ethinyl estradiol0.03 MG / 1 EACHethinyl estradiolethinyl estradiol
ethinyl estradiol0.01 MG / 1 EACHethinyl estradiolethinyl estradiol
levonorgestrel0.15 MG / 1 EACHlevonorgestrellevonorgestrel

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Pack746839

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
ethinyl estradiol4124
levonorgestrel6373

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.

NDC11, Source, Active table
NDC11SourceActive
68180086011rxnav_ndcsyes
68180086012rxnav_ndcsyes
68180086013rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
f49d3256-f665-45ff-a096-3c0fb5979d16These highlights do not include all the information needed to use FAYOSIM safely and effectively. See full prescribing information for FAYOSIM. FAYOSIM™ (levonorgestrel and ethinyl estradiol tablets USP, and ethinyl estradiol tablets USP), for oral use Initial U.S. Approval: 1982Lupin Pharmaceuticals, Inc. | LUPIN LIMITED20191213

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCG03ADEmergency contraceptivesATC1-4levonorgestrel
ATCL02AAEstrogensATC1-4ethinyl estradiol
ATCG03CANatural and semisynthetic estrogens, plainATC1-4ethinyl estradiol
ATCG03ACProgestogensATC1-4levonorgestrel
ATCG03AAProgestogens and estrogens, fixed combinationsATC1-4ethinyl estradiol / levonorgestrel
ATCG03ABProgestogens and estrogens, sequential preparationsATC1-4ethinyl estradiol / levonorgestrel
FDASPLD045167Progesterone CongenersCHEMhas_chemical_structurelevonorgestrel
FDASPLN0000175825EstrogenEPChas_epcethinyl estradiol
FDASPLN0000175602ProgestinEPChas_epclevonorgestrel
FDASPLN0000175832Progestin-containing Intrauterine SystemEPChas_epclevonorgestrel
FDASPLN0000000100Estrogen Receptor AgonistsMOAhas_moaethinyl estradiol
FDASPLN0000175830Inhibit Ovum FertilizationPEhas_pelevonorgestrel
MEDRTD004997Ethinyl EstradiolCHEMhas_ingredientethinyl estradiol
MEDRTD016912LevonorgestrelCHEMhas_ingredientlevonorgestrel
MEDRTD000022Abortion, SpontaneousDISEASEinduceslevonorgestrel
MEDRTD018248Adenoma, Liver CellDISEASEci_withlevonorgestrel
MEDRTD001943Breast NeoplasmsDISEASEci_withethinyl estradiol
MEDRTD001943Breast NeoplasmsDISEASEmay_treatethinyl estradiol
MEDRTD001943Breast NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD002539Cerebral Arterial DiseasesDISEASEci_withethinyl estradiol
MEDRTD002561Cerebrovascular DisordersDISEASEci_withlevonorgestrel
MEDRTD003324Coronary Artery DiseaseDISEASEci_withethinyl estradiol
MEDRTD003327Coronary DiseaseDISEASEci_withlevonorgestrel
MEDRTD003920Diabetes MellitusDISEASEci_withlevonorgestrel
MEDRTD004342Drug HypersensitivityDISEASEci_withethinyl estradiol
MEDRTD004342Drug HypersensitivityDISEASEci_withlevonorgestrel
MEDRTD016889Endometrial NeoplasmsDISEASEci_withethinyl estradiol
MEDRTD016889Endometrial NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD020773Headache DisordersDISEASEci_withlevonorgestrel
MEDRTD006349Heart Valve DiseasesDISEASEci_withlevonorgestrel
MEDRTD019584Hot FlashesDISEASEmay_treatethinyl estradiol
MEDRTD006973HypertensionDISEASEci_withlevonorgestrel
MEDRTD006973HypertensionDISEASEci_withethinyl estradiol
MEDRTD007006HypogonadismDISEASEmay_treatethinyl estradiol
MEDRTD007565JaundiceDISEASEci_withlevonorgestrel
MEDRTD007674Kidney DiseasesDISEASEci_withlevonorgestrel
MEDRTD008107Liver DiseasesDISEASEci_withethinyl estradiol
MEDRTD008107Liver DiseasesDISEASEci_withlevonorgestrel
MEDRTD008113Liver NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD008594Menopause, PrematureDISEASEmay_treatethinyl estradiol
MEDRTD008595MenorrhagiaDISEASEmay_treatethinyl estradiol
MEDRTD009376Neoplasms, Hormone-DependentDISEASEci_withethinyl estradiol
MEDRTD015663Osteoporosis, PostmenopausalDISEASEmay_preventethinyl estradiol
MEDRTD011247PregnancyDISEASEmay_preventethinyl estradiol
MEDRTD011247PregnancyDISEASEmay_preventlevonorgestrel
MEDRTD011247PregnancyDISEASEci_withlevonorgestrel
MEDRTD011247PregnancyDISEASEci_withethinyl estradiol
MEDRTD016649Primary Ovarian InsufficiencyDISEASEmay_treatethinyl estradiol
MEDRTD011471Prostatic NeoplasmsDISEASEmay_treatethinyl estradiol
MEDRTD013923ThromboembolismDISEASEci_withlevonorgestrel
MEDRTD013923ThromboembolismDISEASEci_withethinyl estradiol
MEDRTD013924ThrombophlebitisDISEASEci_withethinyl estradiol
MEDRTD013924ThrombophlebitisDISEASEci_withlevonorgestrel
MEDRTD064424Tobacco UseDISEASEci_withethinyl estradiol
MEDRTD014029Tobacco Use DisorderDISEASEci_withlevonorgestrel
MEDRTD014592Uterine HemorrhageDISEASEci_withlevonorgestrel
MEDRTN0000000100Estrogen Receptor AgonistsMOAhas_moaethinyl estradiol
MEDRTN0000000185Progestational Hormone Receptor AgonistsMOAhas_moalevonorgestrel
MEDRTN0000008311Bone Formation StimulationPEhas_peethinyl estradiol
MEDRTN0000008595Decreased Embryonic ImplantationPEhas_peethinyl estradiol
MEDRTN0000008595Decreased Embryonic ImplantationPEhas_pelevonorgestrel
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_pelevonorgestrel
MEDRTN0000178478Increased Blood PressurePEci_pelevonorgestrel
MEDRTN0000009717Inhibit OvulationPEhas_peethinyl estradiol
MEDRTN0000009717Inhibit OvulationPEhas_pelevonorgestrel
MEDRTN0000009902Vaginal Function AlterationPEhas_peethinyl estradiol
MEDRTN0000008289Aromatic hydroxylationPKhas_pkethinyl estradiol
MEDRTN0000000045Fecal ExcretionPKhas_pkethinyl estradiol
MEDRTN0000000026Hepatic MetabolismPKhas_pkethinyl estradiol
MEDRTN0000000042Renal ExcretionPKhas_pkethinyl estradiol

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
NAMESPrescribable SynonymFayosim 91 Day Pack
SOURCESSourceGold Standard Alchemy
SOURCESSourceMicromedex RED BOOK